| Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma JM Herman, DT Chang, KA Goodman, AS Dholakia, SP Raman, ... Cancer 121 (7), 1128-1137, 2015 | 494 | 2015 |
| Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors SA Grossman, S Ellsworth, J Campian, AT Wild, JM Herman, D Laheru, ... Journal of the National Comprehensive Cancer Network 13 (10), 1225-1231, 2015 | 253 | 2015 |
| Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results JM Herman, AT Wild, H Wang, PT Tran, KJ Chang, GE Taylor, ... Journal of Clinical Oncology 31 (7), 886, 2013 | 205 | 2013 |
| Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer AT Wild, JM Herman, AS Dholakia, S Moningi, Y Lu, LM Rosati, ... International Journal of Radiation Oncology* Biology* Physics 94 (3), 571-579, 2016 | 201 | 2016 |
| The association between chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma AT Wild, X Ye, SG Ellsworth, JA Smith, AK Narang, T Garg, J Campian, ... American journal of clinical oncology 38 (3), 259-265, 2015 | 196 | 2015 |
| G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma Y Wang, J Yang, AT Wild, WH Wu, R Shah, C Danussi, GJ Riggins, ... Nature communications 10 (1), 943, 2019 | 172 | 2019 |
| Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy MA Khashab, KJ Kim, EJ Tryggestad, AT Wild, T Roland, VK Singh, ... Gastrointestinal endoscopy 76 (5), 962-971, 2012 | 105 | 2012 |
| Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience … AT Wild, SM Hiniker, DT Chang, PT Tran, MA Khashab, MR Limaye, ... Journal of gastrointestinal oncology 4 (4), 343, 2013 | 86 | 2013 |
| The twist box domain is required for Twist1-induced prostate cancer metastasis RP Gajula, ST Chettiar, RD Williams, S Thiyagarajan, Y Kato, K Aziz, ... Molecular cancer research 11 (11), 1387-1400, 2013 | 86 | 2013 |
| Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas Y Wang, AT Wild, S Turcan, WH Wu, C Sigel, DS Klimstra, X Ma, Y Gong, ... Science Advances 6 (17), eaaz3221, 2020 | 85 | 2020 |
| Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor–vessel relationships AS Dholakia, A Hacker-Prietz, AT Wild, SP Raman, LD Wood, P Huang, ... Journal of radiation oncology 2, 413-425, 2013 | 85 | 2013 |
| Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits SK Jabbour, S Patel, JM Herman, A Wild, SN Nagda, T Altoos, ... International Journal of Surgical Oncology 2012, 2012 | 74 | 2012 |
| Reliable detection of somatic mutations in fine needle aspirates of pancreatic cancer with next-generation sequencing: implications for surgical management V Valero III, TJ Saunders, J He, MJ Weiss, JL Cameron, A Dholakia, ... Annals of surgery 263 (1), 153-161, 2016 | 57 | 2016 |
| The role of osteotomy in surgical repair of bladder exstrophy AT Wild, PD Sponseller, AA Stec, JP Gearhart Seminars in pediatric surgery 20 (2), 71-78, 2011 | 52 | 2011 |
| Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells N Gandhi, AT Wild, ST Chettiar, K Aziz, Y Kato, RP Gajula, RD Williams, ... Cancer biology & therapy 14 (4), 347-356, 2013 | 51 | 2013 |
| Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas AT Wild, AS Dholakia, KY Fan, R Kumar, S Moningi, LM Rosati, ... Journal of gastrointestinal oncology 6 (2), 115, 2015 | 45 | 2015 |
| Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma AT Wild, N Gandhi, ST Chettiar, K Aziz, RP Gajula, RD Williams, R Kumar, ... PloS one 8 (6), e65726, 2013 | 42 | 2013 |
| Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer JM Herman, KY Fan, AT Wild, A Hacker-Prietz, LD Wood, AL Blackford, ... International Journal of Radiation Oncology* Biology* Physics 86 (4), 678-685, 2013 | 41 | 2013 |
| Molecularly targeted agents as radiosensitizers in cancer therapy—focus on prostate cancer S Alcorn, AJ Walker, N Gandhi, A Narang, AT Wild, RK Hales, JM Herman, ... International journal of molecular sciences 14 (7), 14800-14832, 2013 | 37 | 2013 |
| Treatment options in oligometastatic disease: stereotactic body radiation therapy-focus on colorectal cancer AT Wild, Y Yamada Visceral Medicine 33 (1), 54-61, 2017 | 34 | 2017 |
